Sherman Matthew L
Insider CIK 1325710 · (NLNK) Director · XLRN SVP & Chief Medical Officer · PULM Director · PIRS Director · DCPH EVP & Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 82,265 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 82,000 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 65,900 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 69,100 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | U Tender | 2024-06-11 | 2024-06-11 | 72,261 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | A Award | 2024-06-11 | 2024-06-11 | 34,157 | — | $0 | 144,290 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer | 2024-06-11 | 2024-06-11 | 72,029 | — | $0 | 72,261 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2024-02-16 | 2024-02-20 | 2,615 | $15.62 | $40.8K | 108,739 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2024-02-15 | 2024-02-20 | 69,100 | — | $0 | 69,100 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2024-02-15 | 2024-02-20 | 17,275 | — | $0 | 111,354 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2024-01-16 | 2024-01-18 | 2,435 | $14.47 | $35.2K | 94,079 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-12-13 | 2023-12-14 | 2,792 | $15.37 | $42.9K | 96,514 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2023-12-12 | 2023-12-14 | 8,244 | — | $0 | 99,306 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-10-30 | 2023-10-31 | 2,360 | $12.02 | $28.4K | 90,628 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2023-10-28 | 2023-10-31 | 8,244 | — | $0 | 92,988 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-10-02 | 2023-10-04 | 2,942 | $12.68 | $37.3K | 84,744 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-06-16 | 2023-06-21 | 1,655 | $14.40 | $23.8K | 87,686 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-02-16 | 2023-02-17 | 971 | $15.10 | $14.7K | 88,145 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2023-02-15 | 2023-02-17 | 65,900 | — | $0 | 65,900 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2023-02-15 | 2023-02-17 | 16,488 | — | $0 | 89,116 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-01-17 | 2023-01-19 | 2,403 | $21.24 | $51.0K | 72,628 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2022-10-03 | 2022-10-05 | 2,587 | $18.73 | $48.5K | 74,297 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2022-06-22 | 2022-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2022-06-16 | 2022-06-21 | 1,768 | $10.75 | $19.0K | 76,884 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2022-02-16 | 2022-02-18 | 984 | $9.05 | $8.9K | 76,790 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2022-01-18 | 2022-01-20 | 82,000 | — | $0 | 82,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2022-01-18 | 2022-01-20 | 20,500 | — | $0 | 77,774 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2021-12-15 | 2021-12-17 | 82,265 | — | $0 | 82,265 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2021-12-15 | 2021-12-17 | 11,100 | — | $0 | 57,274 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2021-10-04 | 2021-10-06 | 2,659 | $33.17 | $88.2K | 46,029 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2021-06-25 | 2021-06-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2021-02-16 | 2021-02-18 | 49,900 | — | $0 | 49,900 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2021-02-16 | 2021-02-18 | 11,100 | — | $0 | 48,386 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2021-02-16 | 2021-02-18 | 132 | $48.87 | $6.5K | 37,286 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-12-09 | 2020-12-11 | 207 | — | $0 | 147,096 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-12-09 | 2020-12-11 | 207 | $34.43 | $7.1K | 37,418 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-11-16 | 2020-11-18 | 2,697 | — | $0 | 147,303 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-11-16 | 2020-11-18 | 2,697 | $34.43 | $92.9K | 37,211 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | F Tax w/h | 2020-10-02 | 2020-10-06 | 2,632 | $51.15 | $134.6K | 34,128 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2020-06-23 | 2020-06-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2020-02-18 | 2020-02-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2020-02-18 | 2020-02-20 | 1,760 | — | $0 | 36,760 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2020-01-25 | 2020-01-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2019-10-15 | 2019-10-17 | 150,000 | — | $0 | 150,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2019-10-15 | 2019-10-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 13,889 | — | $0 | 13,889 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 27,777 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 18,506 | — | $0 | 18,506 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 13,218 | — | $0 | 13,218 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 63,447 | — | $0 | 0 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2019-05-16 | 2019-05-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-05-10 | 2019-05-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2019-01-25 | 2019-01-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2018-10-24 | 2018-10-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2018-06-05 | 2018-06-06 | 124,000 | — | $0 | 124,000 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2018-05-23 | 2018-05-25 | 27,777 | — | $0 | 27,777 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy deriv | 2018-04-03 | 2018-04-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy deriv | 2018-04-03 | 2018-04-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-04-03 | 2018-04-04 | 3,700 | $38.28 | $141.6K | 69,667 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-04-03 | 2018-04-04 | 900 | $39.04 | $35.1K | 68,767 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy | 2018-04-03 | 2018-04-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-01-03 | 2018-01-04 | 2,033 | $43.33 | $88.1K | 73,367 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-01-03 | 2018-01-04 | 2,300 | $42.40 | $97.5K | 75,400 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-01-03 | 2018-01-04 | 300 | $40.86 | $12.3K | 77,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-12 | 2017-09-14 | 1,600 | $39.24 | $62.8K | 78,150 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-12 | 2017-09-14 | 16,650 | $38.32 | $638.0K | 79,750 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-12 | 2017-09-14 | 150 | $39.91 | $6.0K | 78,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2017-07-05 | 2017-07-07 | 8,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2017-07-05 | 2017-07-07 | 8,000 | $7.12 | $57.0K | 112,400 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-07-05 | 2017-07-07 | 16,000 | $32.00 | $512.0K | 96,400 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2017-03-20 | 2017-03-22 | 4,400 | — | $0 | 4,400 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2017-03-02 | 2017-03-14 | 47,300 | — | $0 | 47,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2017-03-02 | 2017-03-14 | 7,900 | — | $0 | 104,400 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-01-04 | 2017-01-06 | 400 | $26.81 | $10.7K | 98,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-01-04 | 2017-01-06 | 1,600 | $27.62 | $44.2K | 96,500 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2016-09-29 | 2016-10-03 | 8,800 | — | $0 | 8,800 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-08-10 | 2016-08-11 | 17,000 | — | $0 | 8,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-08-10 | 2016-08-11 | 1,896 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-08-10 | 2016-08-11 | 1,896 | $5.28 | $10.0K | 81,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-08-10 | 2016-08-11 | 17,000 | $7.12 | $121.0K | 98,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-07-07 | 2016-07-07 | 6,000 | — | $0 | 1,896 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-07-07 | 2016-07-07 | 6,000 | $5.28 | $31.7K | 79,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-07-01 | 2016-07-06 | 4,604 | — | $0 | 7,896 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-07-01 | 2016-07-06 | 5,896 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-07-01 | 2016-07-06 | 3,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-07-01 | 2016-07-06 | 5,793 | $34.20 | $198.1K | 93,811 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-07-01 | 2016-07-06 | 4,604 | $5.28 | $24.3K | 99,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-07-01 | 2016-07-06 | 20,207 | $34.89 | $705.0K | 73,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-07-01 | 2016-07-06 | 5,896 | $5.08 | $30.0K | 91,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-07-01 | 2016-07-06 | 3,500 | $3.88 | $13.6K | 95,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-04-07 | 2016-04-08 | 14,000 | — | $0 | 5,896 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-04-07 | 2016-04-08 | 14,000 | $5.08 | $71.1K | 109,524 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-04-07 | 2016-04-08 | 23,920 | $32.00 | $765.4K | 85,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-04-06 | 2016-04-08 | 2,080 | $32.00 | $66.6K | 95,524 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2016-03-03 | 2016-03-07 | 36,000 | — | $0 | 36,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2016-03-03 | 2016-03-07 | 6,000 | — | $0 | 97,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-10-15 | 2015-10-16 | 2,400 | $22.66 | $54.4K | 94,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-10-15 | 2015-10-16 | 2,400 | $23.93 | $57.4K | 91,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-10-15 | 2015-10-16 | 500 | $23.94 | $12.0K | 8,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-10-15 | 2015-10-16 | 700 | $22.69 | $15.9K | 9,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-16 | 2015-09-18 | 300 | $33.55 | $10.1K | 96,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-16 | 2015-09-18 | 1,100 | $32.22 | $35.4K | 96,904 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-16 | 2015-09-18 | 200 | $34.93 | $7.0K | 96,404 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-16 | 2015-09-18 | 400 | $34.96 | $14.0K | 9,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2015-09-09 | 2015-09-11 | 46,000 | — | $0 | 98,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-08-24 | 2015-08-25 | 20,000 | — | $0 | 3,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-08-24 | 2015-08-25 | 20,000 | $3.88 | $77.6K | 52,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-08-18 | 2015-08-19 | 4,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-08-18 | 2015-08-19 | 1,600 | — | $0 | 19,896 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-18 | 2015-08-19 | 200 | $31.69 | $6.3K | 32,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-18 | 2015-08-19 | 400 | $31.95 | $12.8K | 11,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-18 | 2015-08-19 | 800 | $30.99 | $24.8K | 10,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-18 | 2015-08-19 | 200 | $31.69 | $6.3K | 10,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-08-18 | 2015-08-19 | 4,000 | $0.48 | $1.9K | 36,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-18 | 2015-08-19 | 2,790 | $30.83 | $86.0K | 33,214 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-18 | 2015-08-19 | 1,210 | $31.60 | $38.2K | 32,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-08-18 | 2015-08-19 | 1,600 | $5.08 | $8.1K | 33,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-18 | 2015-08-19 | 1,400 | $31.00 | $43.4K | 32,204 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-07-20 | 2015-07-21 | 800 | — | $0 | 21,496 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-07-20 | 2015-07-21 | 4,000 | — | $0 | 4,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-07-20 | 2015-07-21 | 800 | $33.22 | $26.6K | 32,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-07-20 | 2015-07-21 | 4,000 | $0.48 | $1.9K | 36,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-07-20 | 2015-07-21 | 1,000 | $32.31 | $32.3K | 11,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-07-20 | 2015-07-21 | 3,900 | $32.29 | $125.9K | 32,104 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-07-20 | 2015-07-21 | 100 | $32.74 | $3.3K | 32,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-07-20 | 2015-07-21 | 800 | $5.08 | $4.1K | 32,804 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-07-20 | 2015-07-21 | 200 | $33.22 | $6.6K | 11,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-06-18 | 2015-06-19 | 4,000 | — | $0 | 8,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-06-18 | 2015-06-19 | 1,600 | — | $0 | 22,296 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-06-18 | 2015-06-19 | 1,600 | $5.08 | $8.1K | 37,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-06-18 | 2015-06-19 | 5,600 | $31.57 | $176.8K | 32,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-06-18 | 2015-06-19 | 1,000 | $31.57 | $31.6K | 13,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-06-18 | 2015-06-19 | 4,000 | $0.48 | $1.9K | 36,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-06-18 | 2015-06-19 | 400 | $31.07 | $12.4K | 12,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-05-18 | 2015-05-19 | 1,600 | — | $0 | 23,896 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-05-18 | 2015-05-19 | 4,000 | — | $0 | 12,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-05-18 | 2015-05-19 | 4,000 | $0.48 | $1.9K | 36,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-05-18 | 2015-05-19 | 1,400 | $32.20 | $45.1K | 14,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-05-18 | 2015-05-19 | 5,600 | $32.41 | $181.5K | 32,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-05-18 | 2015-05-19 | 1,600 | $5.08 | $8.1K | 37,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-04-20 | 2015-04-21 | 4,000 | — | $0 | 16,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-04-20 | 2015-04-21 | 4,000 | $33.53 | $134.1K | 32,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-04-20 | 2015-04-21 | 1,000 | $33.50 | $33.5K | 15,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-04-20 | 2015-04-21 | 4,000 | $0.48 | $1.9K | 36,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-04-16 | 2015-04-17 | 12,000 | — | $0 | 23,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-04-16 | 2015-04-17 | 12,000 | $3.88 | $46.6K | 32,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-18 | 2015-03-20 | 800 | — | $0 | 25,496 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-18 | 2015-03-20 | 4,000 | — | $0 | 20,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-18 | 2015-03-20 | 900 | $41.13 | $37.0K | 16,800 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-18 | 2015-03-20 | 100 | $41.60 | $4.2K | 16,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-18 | 2015-03-20 | 200 | $41.21 | $8.2K | 16,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-18 | 2015-03-20 | 800 | $41.21 | $33.0K | 20,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-18 | 2015-03-20 | 3,279 | $41.07 | $134.7K | 20,725 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-18 | 2015-03-20 | 721 | $41.63 | $30.0K | 20,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-18 | 2015-03-20 | 800 | $5.08 | $4.1K | 20,804 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-18 | 2015-03-20 | 4,000 | $0.48 | $1.9K | 24,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-04 | 2015-03-06 | 4,000 | — | $0 | 24,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-03-04 | 2015-03-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-04 | 2015-03-06 | 1,600 | — | $0 | 26,296 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 400 | $40.92 | $16.4K | 18,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 1,600 | $40.21 | $64.3K | 20,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-04 | 2015-03-06 | 1,600 | $5.08 | $8.1K | 21,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 200 | $42.07 | $8.4K | 20,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 700 | $40.63 | $28.4K | 18,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 2,799 | $40.66 | $113.8K | 21,205 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-04 | 2015-03-06 | 4,000 | $0.48 | $1.9K | 24,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 300 | $41.38 | $12.4K | 17,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 1,001 | $41.40 | $41.4K | 20,204 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-01-20 | 2015-01-22 | 4,000 | — | $0 | 28,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-01-20 | 2015-01-22 | 1,600 | — | $0 | 27,896 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-20 | 2015-01-22 | 400 | $41.70 | $16.7K | 20,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-20 | 2015-01-22 | 1,000 | $41.60 | $41.6K | 19,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-20 | 2015-01-22 | 2,486 | $41.81 | $103.9K | 24,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-20 | 2015-01-22 | 1,514 | $41.23 | $62.4K | 22,490 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-01-20 | 2015-01-22 | 4,000 | $0.48 | $1.9K | 24,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-20 | 2015-01-22 | 1,600 | $41.78 | $66.8K | 20,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-01-20 | 2015-01-22 | 1,600 | $5.08 | $8.1K | 21,604 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-01-08 | 2015-01-09 | 41,000 | — | $0 | 41,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-12-18 | 2014-12-19 | 4,000 | — | $0 | 32,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-12-18 | 2014-12-19 | 4,000 | $0.48 | $1.9K | 24,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-18 | 2014-12-19 | 1,000 | $40.19 | $40.2K | 20,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-18 | 2014-12-19 | 3,800 | $40.13 | $152.5K | 20,204 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-18 | 2014-12-19 | 200 | $40.60 | $8.1K | 20,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-12-17 | 2014-12-19 | 2,000 | — | $0 | 35,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-12-17 | 2014-12-19 | 2,000 | $3.88 | $7.8K | 20,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-12-10 | 2014-12-12 | 4,000 | — | $0 | 29,496 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-10 | 2014-12-12 | 500 | $43.16 | $21.6K | 22,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-10 | 2014-12-12 | 500 | $43.73 | $21.9K | 21,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-10 | 2014-12-12 | 1,065 | $43.88 | $46.7K | 18,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-10 | 2014-12-12 | 2,935 | $43.32 | $127.1K | 19,069 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-12-10 | 2014-12-12 | 4,000 | $5.08 | $20.3K | 22,004 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-11-18 | 2014-11-18 | 4,082 | — | $0 | 36,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-18 | 2014-11-18 | 700 | $33.42 | $23.4K | 22,800 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-18 | 2014-11-18 | 907 | $34.54 | $31.3K | 19,940 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-18 | 2014-11-18 | 3,175 | $33.54 | $106.5K | 20,847 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-11-18 | 2014-11-18 | 4,082 | $0.48 | $2.0K | 24,022 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-18 | 2014-11-18 | 300 | $34.51 | $10.4K | 22,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-11-12 | 2014-11-14 | 2,414 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-11-12 | 2014-11-14 | 1,504 | — | $0 | 33,496 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-12 | 2014-11-14 | 400 | $33.70 | $13.5K | 23,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-12 | 2014-11-14 | 600 | $32.64 | $19.6K | 23,900 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-12 | 2014-11-14 | 2,317 | $33.59 | $77.8K | 19,940 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-12 | 2014-11-14 | 1,601 | $32.43 | $51.9K | 22,257 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-11-12 | 2014-11-14 | 1,504 | $5.08 | $7.6K | 23,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-11-12 | 2014-11-14 | 2,414 | $1.80 | $4.3K | 22,354 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-10-20 | 2014-10-20 | 3,918 | $29.10 | $114.0K | 19,940 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-10-20 | 2014-10-20 | 1,000 | $29.12 | $29.1K | 24,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-10-08 | 2014-10-09 | 4,082 | — | $0 | 2,414 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-10-08 | 2014-10-09 | 4,082 | $1.80 | $7.3K | 27,940 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-10-08 | 2014-10-09 | 2,889 | $29.17 | $84.3K | 25,051 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-10-08 | 2014-10-09 | 1,193 | $30.28 | $36.1K | 23,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-10-08 | 2014-10-09 | 800 | $29.27 | $23.4K | 25,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-10-08 | 2014-10-09 | 200 | $30.41 | $6.1K | 25,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-09-18 | 2014-09-19 | 4,000 | $25.47 | $101.9K | 23,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-09-18 | 2014-09-19 | 1,000 | $25.50 | $25.5K | 26,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-09-03 | 2014-09-04 | 4,000 | — | $0 | 6,496 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-09-03 | 2014-09-04 | 3,800 | $25.80 | $98.0K | 28,058 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-09-03 | 2014-09-04 | 4,000 | $1.80 | $7.2K | 31,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-09-03 | 2014-09-04 | 200 | $26.40 | $5.3K | 27,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-09-03 | 2014-09-04 | 1,000 | $25.79 | $25.8K | 27,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-08-18 | 2014-08-19 | 500 | $30.00 | $15.0K | 28,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-08-18 | 2014-08-19 | 2,000 | $29.53 | $59.1K | 27,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-08-14 | 2014-08-15 | 4,316 | — | $0 | 10,496 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-08-14 | 2014-08-15 | 1,684 | — | $0 | 40,081 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-08-14 | 2014-08-15 | 4,316 | $1.80 | $7.8K | 35,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-08-14 | 2014-08-15 | 5,900 | $29.77 | $175.6K | 29,958 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-08-14 | 2014-08-15 | 100 | $30.25 | $3.0K | 29,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-08-14 | 2014-08-15 | 1,500 | $29.82 | $44.7K | 29,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-08-14 | 2014-08-15 | 1,684 | $0.48 | $808 | 31,542 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-08-12 | 2014-08-13 | 8,000 | — | $0 | 14,812 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-08-12 | 2014-08-13 | 8,000 | $1.80 | $14.4K | 29,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-07-23 | 2014-07-25 | 10,000 | — | $0 | 22,812 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-07-23 | 2014-07-25 | 10,000 | $1.80 | $18.0K | 21,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-07-18 | 2014-07-22 | 33 | $26.78 | $884 | 11,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-07-18 | 2014-07-22 | 1,967 | $26.39 | $51.9K | 11,891 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-07-18 | 2014-07-22 | 500 | $25.50 | $12.8K | 30,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-07-09 | 2014-07-11 | 6,000 | — | $0 | 41,765 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-07-09 | 2014-07-11 | 2,906 | $28.55 | $83.0K | 16,952 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-07-09 | 2014-07-11 | 6,000 | $0.48 | $2.9K | 19,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-07-09 | 2014-07-11 | 499 | $29.46 | $14.7K | 31,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-07-09 | 2014-07-11 | 1,001 | $28.77 | $28.8K | 31,499 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-07-09 | 2014-07-11 | 3,094 | $29.39 | $90.9K | 13,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-18 | 2014-06-20 | 500 | $34.13 | $17.1K | 32,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-18 | 2014-06-20 | 2,000 | $34.49 | $69.0K | 13,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-06-11 | 2014-06-13 | 6,000 | — | $0 | 47,765 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-11 | 2014-06-13 | 1,500 | $33.25 | $49.9K | 33,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-11 | 2014-06-13 | 6,000 | $33.23 | $199.4K | 15,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-06-11 | 2014-06-13 | 6,000 | $0.48 | $2.9K | 21,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-05-28 | 2014-05-30 | 6,000 | — | $0 | 53,765 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-28 | 2014-05-30 | 6,000 | $30.97 | $185.8K | 15,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-28 | 2014-05-30 | 1,500 | $30.99 | $46.5K | 34,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-05-28 | 2014-05-30 | 6,000 | $0.48 | $2.9K | 21,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-12-12 | 100 | $32.23 | $3.2K | 13,922 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-12-12 | 1,900 | $31.47 | $59.8K | 14,022 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-05-21 | 1,900 | $31.47 | $59.8K | 15,958 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-05-21 | 100 | $32.23 | $3.2K | 15,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-05-21 | 500 | $31.68 | $15.8K | 36,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-04-22 | 2014-04-24 | 1,000 | $35.75 | $35.8K | 36,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-04-22 | 2014-04-24 | 2,064 | $35.64 | $73.6K | 17,858 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-04-22 | 2014-04-24 | 1,936 | $36.08 | $69.9K | 15,922 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2013-12-05 | 2013-12-09 | 29,000 | — | $0 | 29,000 | SEC↗ |